Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 206 participants.

Also called NCT02984982

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 206 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02984982
Other papers using this trial's data
  • Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients With Acute Coronary Syndrome - The ODYSSEY J-IVUS Trial Circulation journal : official journal of the Japanese Circulation Society, 2019-09-25 DOI, PubMed 31434809

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Japan (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02984982. Randomized; no masking; primary purpose treatment. Start 2016-11-15 (actual); primary completion 2018-07-27 (actual). Results posted on 2019-09-09.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia
Acronym
ODYSSEY J-IVUS
Condition
Hypercholesterolemia
Condition
Acute Coronary Syndrome
Intervention (Drug)
Alirocumab SAR236553
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Rosuvastatin
Intervention (Drug)
Fenofibrate
Intervention (Drug)
Bezafibrate
Intervention (Drug)
Ezetimibe
Intervention (Drug)
Antiplatelets
Intervention (Drug)
Anticoagulants
Lead sponsor
Sanofi (class: industry)
Collaborator
Regeneron Pharmaceuticals (class: industry)

Record details

Record id
cardio:ct-nct02984982
Content hash
0d15326036b6fdfca938899cdf4e195238861da606325012ee5ab33e477ba067